持続性心房細動に対する新しい左心耳隔離戦略:再アブレーションが必要な場合
Patricia Tung1, Juliana Pérez-Pinzón2, Daniel Villarreal Garcia1
1Harvard Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Heart rhythm
|December 21, 2025
まとめ
左心耳隔離(LAAI)は、前部および後部僧帽弁線とマーシャル静脈エタノールアブレーションを使用した持続性心房細動(AF)患者に対して実行可能です。このアプローチは、持続的なLAAIと不整脈再発の減少を示し、報告された脳卒中はありません。
科学分野:
- 心臓学
- 電気生理学
- 医療機器
背景:
- 左心耳(LAA)は、再アブレーションを受ける患者における心房細動(AF)トリガーの重要な発生源である。
- 以前の左心耳隔離(LAAI)法は、成功率やリスクが様々であった。
主な方法:
- 持続性AFに対する再アブレーションを受けた23人の患者を対象とした前向き研究。
- AMLおよびPMLを使用し、VOMの有無にかかわらずLAAIを実施した。
- LAAIの持続性評価のための系統的再マッピングと、不整脈のない生存期間のためのカプランマイヤー分析を実施した。
結論:
- VOMを用いた線状AMLおよびPMLアプローチによるLAAIは、実現可能で再現性がある。
- この技術は、自己限定的な不整脈再発の低い率につながる。
- この方法は、安全性と持続性AFにおける予後の改善の可能性を示す。
関連する概念動画
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


